Saliya, Sentayehu Admasu
Ashine, Taye Mezgebu
Heliso, Asnakech Zekiwos
Babore, Getachew Ossabo
Birhanu, Bethelhem
Hailu, Awoke Girma
Article History
Received: 27 November 2023
Accepted: 17 June 2024
First Online: 21 June 2024
Declarations
:
: Ethical clearance was obtained from the Wachemo University College of Medicine and Health Science, with reference number IRB/172/16. In Ethiopia, we did not ask the National Research Ethics Review Committee (NRERC) to obtain ethical approval/waiver for the following two reasons: (a) This study had no significant risks on study participants as approved by Wachemo University College of Medicine and Health Science, with reference number IRB/172/16; (b) NRERC is primarily focused on providing ethical decisions for clinical trials involving new drugs, experimental research, and studies that require human biological specimens/samples. Instead of NRERC ethical approval, the human resources for health experts at Wachemo.The University Institutional Review Board (IRB) of the College of Medicine and Health Science reviewed the study protocol and granted permission to conduct the study. Written informed consent was approved by the Wachemo University College of Medicine and Health Science Institutional Review Board. Written informed consent was obtained from all study participants.To protect participants from risks, the study did not record participants’ names, identification numbers, and names of health facilities where he or she worked. Data were also entered into a computer with unique randomly generated ID numbers given for each study participant. All methods were carried out following relevant guidelines and regulations.
: Not applicable.
: The authors declare no competing interests.